Blog

Pilocarpine eye drops improve outcomes after Kahook Dual Blade goniotomy surgery

# Pilocarpine Eye Drops Enhance Results After Kahook Dual Blade Goniotomy ## Introduction Glaucoma is a leading cause of irreversible blindness worldwide, and surgical interventions like the Kahook Dual Blade (KDB) goniotomy have emerged as effective treatments to lower intraocular pressure (IOP). However, recent studies suggest that combining KDB with pilocarpine eye drops can further […]

Pilocarpine eye drops improve outcomes after Kahook Dual Blade goniotomy surgery Read More »

Sanoculis wins CE mark for minimally invasive glaucoma treatment device

# Sanoculis Secures CE Mark for Innovative Glaucoma Treatment Device ## Introduction In a significant milestone for ophthalmic innovation, **Sanoculis** has recently obtained the **CE Mark** for its groundbreaking glaucoma treatment device. This regulatory approval paves the way for the commercialization of their cutting-edge technology in **Europe**, offering new hope for patients suffering from this

Sanoculis wins CE mark for minimally invasive glaucoma treatment device Read More »

Army Hospital introduces 3D microscope for minimally invasive glaucoma surgery –

Army Hospital Pioneers 3D Microscope for Glaucoma Surgery Breakthroughs In a groundbreaking development, an Army hospital has introduced a cutting-edge 3D microscope to revolutionize glaucoma surgery. This innovative technology promises to enhance precision, improve surgical outcomes, and reduce recovery times for patients suffering from this sight-threatening condition. With glaucoma affecting millions worldwide, this advancement could

Army Hospital introduces 3D microscope for minimally invasive glaucoma surgery – Read More »

Reimagining Indian Healthcare

Transforming Indian Healthcare for a Brighter Future The Indian healthcare system has come a long way, yet challenges persist. With a growing population, increasing healthcare demands, and the need for equitable access, India stands at a critical juncture. Transforming Indian healthcare is not just a necessity—it’s an opportunity to build a healthier, more prosperous nation.

Reimagining Indian Healthcare Read More »

Does Glaucoma Run in Families?

Does Glaucoma Run in Families? Hereditary Risks Explained Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. One of the most common questions patients ask is: does glaucoma run in families? The answer is yes—research shows that genetics play a significant role in glaucoma risk. Understanding the hereditary factors can help

Does Glaucoma Run in Families? Read More »

Reimagining Indian Healthcare

Transforming Indian Healthcare for a Brighter Future The Indian healthcare system is at a pivotal moment. With a growing population, increasing life expectancy, and rising healthcare demands, the need for transformation has never been more urgent. From digital innovations to policy reforms, India is taking bold steps to ensure a healthier future for its citizens.

Reimagining Indian Healthcare Read More »

Open Angle Glaucoma Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight

Open Angle Glaucoma Clinical Trials and FDA Approvals 2025 Analysis Open-angle glaucoma (OAG) remains one of the leading causes of irreversible blindness worldwide. As research advances, 2025 is poised to be a pivotal year for clinical trials and FDA approvals in this space. This article delves into the latest developments, emerging therapies, and regulatory milestones

Open Angle Glaucoma Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight Read More »

NESC Begins New Software in Eye Healthcare Service in Liberia

NESC Launches Innovative Eye Healthcare Software in Liberia In a groundbreaking move to revolutionize eye healthcare in Liberia, the National Eye Care Services (NESC) has introduced an innovative software solution designed to enhance diagnosis, treatment, and patient management. This cutting-edge technology aims to address the growing need for accessible and efficient eye care services across

NESC Begins New Software in Eye Healthcare Service in Liberia Read More »

Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma

Rare PTPRB Gene Linked to Eye and Vein Disorders Recent scientific discoveries have shed light on the role of the PTPRB gene in the development of rare eye and vein disorders. This gene, which encodes a protein tyrosine phosphatase, plays a crucial role in vascular development and maintenance. Mutations in PTPRB have now been linked

Rare genetic variation in PTPRB is associated with central serous chorioretinopathy, varicose veins and glaucoma Read More »

ARVO 2025: Cross-attention network for glaucoma classification

ARVO 2025: Breakthrough Cross-Attention Network for Glaucoma Detection Glaucoma, a leading cause of irreversible blindness worldwide, has long posed challenges for early detection and accurate diagnosis. However, a groundbreaking innovation unveiled at ARVO 2025 promises to revolutionize glaucoma screening—the Cross-Attention Network (CAN). This cutting-edge deep learning model leverages advanced attention mechanisms to enhance diagnostic precision,

ARVO 2025: Cross-attention network for glaucoma classification Read More »

Scroll to Top